Notably, the remodeling of immune cells inside the tumor microenvironment, manifested with an increase of CD8 + T cells, CD4 + T cells, DC cells, NK cells, M1 TAMs, and a decrease of Tregs, MDSCs, and M2 TAMs upon the treatment, led to inhibition of tumor growth. This evidence concerns the gene CD8A and neoplasm.